Literature DB >> 21218193

Enigmatic MYC Conducts an Unfolding Systems Biology Symphony.

Chi V Dang1.   

Abstract

The enigmatic MYC oncogene, which participates broadly in cancers, revealed itself recently as the maestro of an unfolding symphony of cell growth, proliferation, death, and metabolism. The study of MYC is arguably most challenging to its students but at the same time exhilarating when MYC reveals its deeply held secrets. It is the excitement of our richer understanding of MYC that is captured in each review of this special issue of Genes & Cancer. Collectively, our deeper understanding of MYC reveals that it is a symphony conductor, controlling a large orchestra of target genes. Although MYC controls many orchestra sections, which are necessary but not sufficient for Myc function, ribosome biogenesis stands out to reveal Myc's primordial function particularly in fruit flies. Because ribosome biogenesis and the associated translational machinery are bioenergetically demanding, Myc's other target genes involved in energy metabolism must be coupled with energy demand to ensure that cells can replicate their genome and produce daughter cells. Normal cells have feedback loops that diminish MYC expression when nutrients are scarce. On the other hand, when deregulated Myc transforms cells, their constitutive bioenergetic demand can trigger cell death when energy is unavailable. This special issue captures the unfolding symphony of MYC-mediated tumorigenesis through reviews that span from a timeline of MYC research, fundamental understanding of how the MYC gene itself is regulated, the study of Myc in model organisms, Myc function, and target genes to translational research in search of new therapeutic modalities for the treatment of cancer.

Entities:  

Year:  2010        PMID: 21218193      PMCID: PMC3017351          DOI: 10.1177/1947601910378742

Source DB:  PubMed          Journal:  Genes Cancer        ISSN: 1947-6019


  68 in total

1.  Myc inhibits p27-induced erythroid differentiation of leukemia cells by repressing erythroid master genes without reversing p27-mediated cell cycle arrest.

Authors:  Juan C Acosta; Nuria Ferrándiz; Gabriel Bretones; Verónica Torrano; Rosa Blanco; Carlos Richard; Brenda O'Connell; John Sedivy; M Dolores Delgado; Javier León
Journal:  Mol Cell Biol       Date:  2008-10-06       Impact factor: 4.272

2.  Functional cis-regulatory genomics for systems biology.

Authors:  Jongmin Nam; Ping Dong; Ryan Tarpine; Sorin Istrail; Eric H Davidson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-08       Impact factor: 11.205

3.  Myc and Max homologs in Drosophila.

Authors:  P Gallant; Y Shiio; P F Cheng; S M Parkhurst; R N Eisenman
Journal:  Science       Date:  1996-11-29       Impact factor: 47.728

4.  Myc Regulation of mRNA Cap Methylation.

Authors:  Victoria H Cowling; Michael D Cole
Journal:  Genes Cancer       Date:  2010-06

5.  Emerging Concepts in the Analysis of Transcriptional Targets of the MYC Oncoprotein: Are the Targets Targetable?

Authors:  Chi Van Dang; Steven B McMahon
Journal:  Genes Cancer       Date:  2010-06

6.  Transcriptional repression: the dark side of myc.

Authors:  Barbara Herkert; Martin Eilers
Journal:  Genes Cancer       Date:  2010-06

Review 7.  MYC in breast tumor progression.

Authors:  Yinghua Chen; Olufunmilayo I Olopade
Journal:  Expert Rev Anticancer Ther       Date:  2008-10       Impact factor: 4.512

8.  MYC is amplified in BRCA1-associated breast cancers.

Authors:  Tatyana A Grushko; James J Dignam; Soma Das; Anne M Blackwood; Charles M Perou; Karin K Ridderstråle; Kristin N Anderson; Min-Jie Wei; April J Adams; Fitsum G Hagos; Lise Sveen; Henry T Lynch; Barbara L Weber; Olufunmilayo I Olopade
Journal:  Clin Cancer Res       Date:  2004-01-15       Impact factor: 12.531

9.  How the c-myc promoter works and why it sometimes does not.

Authors:  David Levens
Journal:  J Natl Cancer Inst Monogr       Date:  2008

10.  Small molecule inhibitors of Myc/Max dimerization and Myc-induced cell transformation.

Authors:  Jin Shi; James S Stover; Landon R Whitby; Peter K Vogt; Dale L Boger
Journal:  Bioorg Med Chem Lett       Date:  2009-09-17       Impact factor: 2.823

View more
  32 in total

1.  Demonstration that drug-targeted down-regulation of MYC in non-Hodgkins lymphoma is directly mediated through the promoter G-quadruplex.

Authors:  Robert V Brown; Forest L Danford; Vijay Gokhale; Laurence H Hurley; Tracy A Brooks
Journal:  J Biol Chem       Date:  2011-09-28       Impact factor: 5.157

2.  Protein and nucleotide biosynthesis are coupled by a single rate-limiting enzyme, PRPS2, to drive cancer.

Authors:  John T Cunningham; Melissa V Moreno; Alessia Lodi; Sabrina M Ronen; Davide Ruggero
Journal:  Cell       Date:  2014-05-22       Impact factor: 41.582

3.  Kinetic profiling of the c-Myc transcriptome and bioinformatic analysis of repressed gene promoters.

Authors:  Chui-Sun Yap; Abigail L Peterson; Gastone Castellani; John M Sedivy; Nicola Neretti
Journal:  Cell Cycle       Date:  2011-07-01       Impact factor: 4.534

4.  Proteomic profiling of high risk medulloblastoma reveals functional biology.

Authors:  Jerome A Staal; Ling San Lau; Huizhen Zhang; Wendy J Ingram; Andrew R Hallahan; Paul A Northcott; Stefan M Pfister; Robert J Wechsler-Reya; Jessica M Rusert; Michael D Taylor; Yoon-Jae Cho; Roger J Packer; Kristy J Brown; Brian R Rood
Journal:  Oncotarget       Date:  2015-06-10

5.  Wedelolactone, an Anti-inflammatory Botanical, Interrupts c-Myc Oncogenic Signaling and Synergizes with Enzalutamide to Induce Apoptosis in Prostate Cancer Cells.

Authors:  Sivalokanathan Sarveswaran; Ritisha Ghosh; Rujul Parikh; Jagadananda Ghosh
Journal:  Mol Cancer Ther       Date:  2016-07-29       Impact factor: 6.261

6.  c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells.

Authors:  Zuqin Nie; Gangqing Hu; Gang Wei; Kairong Cui; Arito Yamane; Wolfgang Resch; Ruoning Wang; Douglas R Green; Lino Tessarollo; Rafael Casellas; Keji Zhao; David Levens
Journal:  Cell       Date:  2012-09-28       Impact factor: 41.582

7.  N-Myc and L-Myc are essential for hair cell formation but not maintenance.

Authors:  Benjamin J Kopecky; Rhonda Decook; Bernd Fritzsch
Journal:  Brain Res       Date:  2012-09-25       Impact factor: 3.252

8.  ER stress-mediated autophagy promotes Myc-dependent transformation and tumor growth.

Authors:  Lori S Hart; John T Cunningham; Tatini Datta; Souvik Dey; Feven Tameire; Stacey L Lehman; Bo Qiu; Haiyan Zhang; George Cerniglia; Meixia Bi; Yan Li; Yan Gao; Huayi Liu; Changhong Li; Amit Maity; Andrei Thomas-Tikhonenko; Alexander E Perl; Albert Koong; Serge Y Fuchs; J Alan Diehl; Ian G Mills; Davide Ruggero; Constantinos Koumenis
Journal:  J Clin Invest       Date:  2012-11-12       Impact factor: 14.808

9.  The soy isoflavone equol may increase cancer malignancy via up-regulation of eukaryotic protein synthesis initiation factor eIF4G.

Authors:  Columba de la Parra; Elisa Otero-Franqui; Michelle Martinez-Montemayor; Suranganie Dharmawardhane
Journal:  J Biol Chem       Date:  2012-10-24       Impact factor: 5.157

10.  Impact of c-MYC protein expression on outcome of patients with early-stage HER2+ breast cancer treated with adjuvant trastuzumab NCCTG (alliance) N9831.

Authors:  Amylou C Dueck; Monica M Reinholz; Xochiquetzal J Geiger; Kathleen Tenner; Karla Ballman; Robert B Jenkins; Darren Riehle; Beiyun Chen; Ann E McCullough; Nancy E Davidson; Silvana Martino; George W Sledge; Peter A Kaufman; Leila A Kutteh; Julie Gralow; Lyndsay N Harris; James N Ingle; Wilma L Lingle; Edith A Perez
Journal:  Clin Cancer Res       Date:  2013-08-21       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.